• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外血液滤过:一种通过动脉内化疗降低全身药物暴露的模型。

Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy.

作者信息

Graham R A, Siddik Z H, Hohn D C

机构信息

Department of General Surgery, University of Texas M.D. Anderson Cancer Center, Houston 77030.

出版信息

Cancer Chemother Pharmacol. 1990;26(3):210-4. doi: 10.1007/BF02897201.

DOI:10.1007/BF02897201
PMID:2357769
Abstract

Cisplatin (3 mg/kg) was infused through the hepatic artery in nine mongrel dogs. Four of these dogs underwent simultaneous extracorporeal hemofiltration (ECH) of the hepatic venous effluent using a high-flow, dual-lumen catheter placed in the vena cava at the level of the hepatic veins. Platinum levels were measured in the plasma, urine, and ultrafiltrate and in kidney and liver tissue. ECH significantly reduced systemic drug exposure as measured by the AUC for free and total platinum, by urinary excretion, and by 24-h kidney levels. Regional liver levels were minimally affected. Recovery of platinum in the ultrafiltrate was 40% +/- 14%. ECH resulted in efficient extraction of platinum and reduced systemic drug exposure with relative preservation of regional hepatic drug exposure.

摘要

对9只杂种犬经肝动脉输注顺铂(3毫克/千克)。其中4只犬同时使用置于肝静脉水平下腔静脉的高流量双腔导管对肝静脉流出液进行体外血液滤过(ECH)。测定血浆、尿液、超滤液以及肾脏和肝脏组织中的铂水平。通过游离铂和总铂的AUC、尿排泄量以及24小时肾脏水平测定,ECH显著降低了全身药物暴露。局部肝脏水平受影响最小。超滤液中铂的回收率为40%±14%。ECH可有效提取铂并减少全身药物暴露,同时相对保留局部肝脏药物暴露。

相似文献

1
Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy.体外血液滤过:一种通过动脉内化疗降低全身药物暴露的模型。
Cancer Chemother Pharmacol. 1990;26(3):210-4. doi: 10.1007/BF02897201.
2
Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration: a feasibility study of a novel system.肝动脉灌注化疗联合完全肝静脉隔离及体外化学滤过:一种新型系统的可行性研究
Anticancer Drugs. 1991 Apr;2(2):175-83. doi: 10.1097/00001813-199104000-00008.
3
Novel Extracorporeal Hemoperfusion System for Hepatic Arterial Infusion of Cisplatin.用于肝动脉灌注顺铂的新型体外血液灌注系统。
Anticancer Res. 2018 Nov;38(11):6445-6452. doi: 10.21873/anticanres.13006.
4
Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration.在完全肝静脉隔离和体外化学滤过的情况下,肝动脉灌注阿霉素后全身药物暴露量的降低。
Surgery. 1993 Sep;114(3):579-85.
5
Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors.
Am J Surg. 1997 Feb;173(2):103-9. doi: 10.1016/S0002-9610(96)00422-9.
6
Potential advantages of loco-regional intra-arterial chemotherapy.
In Vivo. 2006 Nov-Dec;20(6A):777-9.
7
Extracorporeal cisplatin removal using direct hemoperfusion under hepatic venous isolation for hepatic arterial chemotherapy: an experimental study on pharmacokinetics.肝动脉化疗时在肝静脉隔离下采用直接血液灌流进行体外顺铂清除:药代动力学的实验研究
Surg Today. 1993;23(1):58-62. doi: 10.1007/BF00309001.
8
Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study.完全性肝静脉隔离及体外化学滤过治疗人肝细胞癌:一项I期研究
Ann Surg Oncol. 1994 Sep;1(5):389-99. doi: 10.1007/BF02303811.
9
[Comparison of hepatic tissue extraction rates of cytotoxic anticancer drugs during hepatic arterial chemotherapy--evaluation using direct hemoperfusion under hepatic venous isolation].肝动脉化疗期间细胞毒性抗癌药物肝组织提取率的比较——肝静脉隔离下直接血液灌注的评估
Nihon Shokakibyo Gakkai Zasshi. 1993 Jan;90(1):41-8.
10
Pharmacokinetics of cisplatin regional hepatic infusions.
Am J Clin Oncol. 1982 Apr;5(2):173-8. doi: 10.1097/00000421-198204000-00065.

引用本文的文献

1
Isolated liver perfusion using percutaneous methods: an experimental study in the pig.经皮方法进行的离体肝脏灌注:在猪身上的实验研究
Cardiovasc Intervent Radiol. 1996 Nov-Dec;19(6):418-22. doi: 10.1007/BF02577630.
2
Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration.通过完全肝静脉隔离和体外化学滤过实现肝肿瘤中阿霉素水平升高,同时全身药物暴露减少。
Cancer Chemother Pharmacol. 1993;33(3):251-7. doi: 10.1007/BF00686224.

本文引用的文献

1
Dose: a critical factor in cancer chemotherapy.剂量:癌症化疗中的关键因素。
Am J Med. 1980 Oct;69(4):585-94. doi: 10.1016/0002-9343(80)90472-6.
2
Arterial drug infusion with extracorporeal removal. I. Theoretic basis with particular reference to the brain.
Cancer Treat Rep. 1984 Feb;68(2):373-80.
3
Pharmacologic rationale for regional drug delivery.区域给药的药理学原理。
J Clin Oncol. 1984 May;2(5):498-504. doi: 10.1200/JCO.1984.2.5.498.
4
Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study.
Cancer. 1984 Aug 1;54(3):387-92. doi: 10.1002/1097-0142(19840801)54:3<387::aid-cncr2820540303>3.0.co;2-w.
5
Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses.动脉内输注抗癌药物:药物递送的理论方面及反应综述
Cancer Treat Rep. 1980 Jan;64(1):31-40.
6
A critical evaluation of the principles governing the advantages of intra-arterial infusions.对动脉内输注优势相关原则的批判性评估。
J Pharmacokinet Biopharm. 1974 Jun;2(3):257-85. doi: 10.1007/BF01059765.
7
Reduced systemic drug exposure by combining intra-arterial chemotherapy with hemoperfusion of regional venous drainage.
J Neurosurg. 1985 Nov;63(5):726-32. doi: 10.3171/jns.1985.63.5.0726.
8
Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage.通过动脉内注射顺二氯二氨铂(II)与局部静脉引流血液透析相结合来降低全身药物暴露。
Cancer Res. 1987 Apr 1;47(7):1962-7.
9
Indications and therapeutic possibilities using degradable microspheres in liver malignancies.可降解微球在肝脏恶性肿瘤中的应用指征及治疗可能性
Recent Results Cancer Res. 1986;100:282-8. doi: 10.1007/978-3-642-82635-1_35.
10
Pharmacologic rationale for hepatic arterial therapy.肝动脉治疗的药理学原理。
Recent Results Cancer Res. 1986;100:140-7. doi: 10.1007/978-3-642-82635-1_18.